Calypso® Medical and Philips Announce Strategic Collaboration to Improve Precision of Cancer Treatment 

New collaboration brings together innovations in target localization and treatment planning systems 

Atlanta – October 5, 2004 – Calypso® Medical, a medical device company focused on addressing unmet needs in radiation therapy, today announced a strategic collaboration with Philips Medical Systems that will enable the development of products with the potential to deliver both adaptive and image-guided radiation therapy. The collaboration was announced at the 46th Annual American Society for Therapeutic Radiology and Oncology (ASTRO) meeting, taking place in Atlanta, October 3 - 7. 

Philips expects to provide enhancements to its treatment planning systems with target localization data from the Calypso® 4D Localization System as a result of this collaboration. The Calypso® 4D Localization System was designed to provide an objective and continuous method to setup treatment and monitor the patient during radiation delivery without adding ionizing radiation. 

“Working together with the leaders in the field of radiation therapy we can provide the ‘missing link’ to advance radiation treatment options,” said Eric R. Meier, Calypso Medical’s President and CEO. “Today’s highly conformal radiation therapy treatment options rely on knowing the exact location of the target moment to moment. Establishing a relationship with Philips marks a commitment to advance planning and delivery techniques such as adaptive radiation therapy.” 

Using its proprietary AC electromagnetic technology, the Calypso System provides an unparalleled capability to pinpoint the target continuously throughout the treatment process, without adding ionizing radiation. The open-system architecture design enables the integration of localization and tracking information throughout the care pathway from simulation through treatment delivery. 

"Philips is committed to providing integrated state-of-the-art solutions for the most challenging problems facing cancer care, both today and in the future. This relationship further demonstrates that commitment," said Keith Tipton, general manager, radiation oncology, for Philips Medical Systems. "Calypso Medical's technology, in conjunction with the Pinnacle3 and AcQSim treatment planning and simulation solutions from Philips, has the potential to deliver on the promise of adaptive and image guided radiation therapy. The end result is expected to be among the most precise treatments available to patients." 

About Royal Philips Electronics 

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is one of the world's biggest electronics companies and Europe's largest, with sales of $32.8 billion (EUR 29 billion) in 2003. With activities in the three interlocking domains of healthcare, lifestyle and technology and 165,600 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions.

20041005_philips.pdf